These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8905920)

  • 1. Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals.
    Lewis DF; Eddershaw PJ; Goldfarb PS; Tarbit MH
    Xenobiotica; 1996 Oct; 26(10):1067-86. PubMed ID: 8905920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform.
    Lewis DF; Bird MG; Dickins M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Xenobiotica; 2000 Jan; 30(1):1-25. PubMed ID: 10659948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism.
    Lewis DF; Eddershaw PJ; Goldfarb PS; Tarbit MH
    Xenobiotica; 1997 Apr; 27(4):319-39. PubMed ID: 9149373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling of CYP4A subfamily members based on sequence homology with CYP102.
    Lewis DF; Lake BG
    Xenobiotica; 1999 Aug; 29(8):763-81. PubMed ID: 10553718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CYP2 family: models, mutants and interactions.
    Lewis DF
    Xenobiotica; 1998 Jul; 28(7):617-61. PubMed ID: 9711809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives.
    Lewis DF; Wiseman A; Tarbit MH
    J Enzyme Inhib; 1999; 14(3):175-92. PubMed ID: 10445042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.
    Lewis DF
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):369-74. PubMed ID: 10445400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions.
    Lewis DF; Lake BG; Dickins M; Goldfarb PS
    Xenobiotica; 2004 Jun; 34(6):549-69. PubMed ID: 15277015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modelling of the mouse cytochrome P450 CYP2F2 based on the CYP102 crystal structure template and selective CYP2F2 substrate interactions.
    Lewis DF; Bailey PT; Low LK
    Drug Metabol Drug Interact; 2002; 19(2):97-113. PubMed ID: 12751909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.
    Lewis DF; Lake BG; George SG; Dickins M; Eddershaw PJ; Tarbit MH; Beresford AP; Goldfarb PS; Guengerich FP
    Toxicology; 1999 Nov; 139(1-2):53-79. PubMed ID: 10614688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure.
    Lewis DF; Lee-Robichaud P
    J Steroid Biochem Mol Biol; 1998 Aug; 66(4):217-33. PubMed ID: 9744519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4.
    Lewis DF; Lake BG; Dickins M; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Xenobiotica; 1999 Apr; 29(4):361-93. PubMed ID: 10375007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody.
    Schulz-Utermoehl T; Mountfield RJ; Bywater RP; Madsen K; Jørgensen PN; Hansen KT
    Drug Metab Dispos; 2000 Jul; 28(7):718-25. PubMed ID: 10859142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modelling of the enzyme P450 17 alpha-hydroxylase/17,20-lyase--a target for prostate cancer chemotherapy--from the crystal structure of P450BM-3.
    Burke DF; Laughton CA; Neidle S
    Anticancer Drug Des; 1997 Mar; 12(2):113-23. PubMed ID: 9113066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity.
    Lewis DF; Dickins M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Toxicology; 1999 Mar; 133(1):1-33. PubMed ID: 10413191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and MeIQ.
    Lozano JJ; López-de-Briñas E; Centeno NB; Guigó R; Sanz F
    J Comput Aided Mol Des; 1997 Jul; 11(4):395-408. PubMed ID: 9334905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3.
    Anzenbacherová E; Bec N; Anzenbacher P; Hudecek J; Soucek P; Jung C; Munro AW; Lange R
    Eur J Biochem; 2000 May; 267(10):2916-20. PubMed ID: 10806389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3).
    Lewis DF
    Xenobiotica; 1995 Apr; 25(4):333-66. PubMed ID: 7645302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the CYP3A4 active site by homology modeling.
    Tanaka T; Okuda T; Yamamoto Y
    Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):830-5. PubMed ID: 15256703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.